CIPREC Centro de Investigación y Prevención Cardiovascular - CABA

Centro de Atención Médica dedicado a la conducción de Estudios de Investigación Clínica en diferentes fases de desarrollo con más de 10 años de experiencia en diversas áreas de especialización.
logoCIPREC Centro de Investigación y Prevención Cardiovascular - CABA
Av. Pueyrredon 1746, CABA, Buenos Aires
Select an option
Specializations
Diabetes
Gastroparesia diabética
Obesidad
Colangitis biliar primaria
Cardiovascular
Enfermedad renal crónica
Hígado graso
Covid-19
Our team
Medical staff
Cesar Javier Zaidman
Fernando Gruz
Ezequiel Slutsky
Pablo Olivera Sendra
Eliana Serrano
Luciana Casalla
Fernando Guerlloy
Irene Copati
Noelia Broqua
Tania Zarowsky
Mariano Gabriel Marini
Open studies
Breast Cancer
A Study of Imlunestrant Versus Standard Endocrine Therapy in Participants With Early Breast Cancer - EMBER-4 - Eli Lilly and CompanySee more
A Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years of Standard Adjuvant Endocrine Therapy - CAMBRIA-1 - AstraZenecaSee more
A Study to Learn About the Study Medicine Called PF-07220060 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment - PfizerSee more
Hypercholesterolemia
Enlicitide Decanoate (MK-0616 Oral PCSK9 Inhibitor) Cardiovascular Outcomes Study (MK-0616-015) CORALreef Outcomes - CORALreef Outcomes - MK-0616-015 - Merck Sharp & Dohme LLCSee more
A Study to Evaluate the Efficacy and Safety of Enlicitide Decanoate (MK-0616, Oral PCSK9 Inhibitor) Compared With Ezetimibe or Bempedoic Acid or Ezetimibe and Bempedoic Acid in Adults With Hypercholesterolemia (MK-0616-018) CORALreef AddOn - Merck Sharp & Dohme LLCSee more
Alopecia
A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants with Severe Alopecia Areata - Up-AA - AbbVieSee more
Cardiovascular disease
Enlicitide Decanoate (MK-0616 Oral PCSK9 Inhibitor) Cardiovascular Outcomes Study (MK-0616-015) CORALreef Outcomes - CORALreef Outcomes - MK-0616-015 - Merck Sharp & Dohme LLCSee more
Depression
A Study of Aticaprant as Adjunctive Therapy in Adult Participants With Major Depressive Disorder (MDD) With Moderate-to-severe Anhedonia and Inadequate Response to Current Antidepressant Therapy - VENTURA-1 - Janssen Research & Development, LLCSee more
Diabetes
Effect of Retatrutide Compared With Semaglutide in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Metformin With or Without SGLT2 Inhibitor (TRANSCEND-T2D-2) - Eli Lilly and CompanySee more
LinkedinInstagramFacebook
Terms and ConditionsPrivacy Policy